![]()
REFERENCES
Aarskog, D. (1970) ‘A familial syndrome of short stature associated with facial dysplasia and genital anomalies.’ Journal of Pediatrics, 77: 856–861.
Abel, T. and Zukin, R.S. (2008) ‘Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders.’, Current Opinion in Pharmacology, 8: 57–64.
Abelson, J.F., Kwan, K.Y., O’Roak, B.J., Baek, D.Y. et al. (2005) ‘Sequence variants in SLITRK1 are associated with Tourette’s syndrome.’, Science, 310: 317–320.
Abitbol, M., Menini, C., Delezoide, A-L., Rhyner, T. et al. (1993) ‘Nucleus basalis magnocellularis and hippocampus are the major sites of FMR-1 expression in the human foetal brain.’, Nature Genetics, 4: 147–153.
Abizaid, A., Liu, Z-W., Andrews, Z.B., Shanabrough, M. et al. (2006) ‘Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite.’, Journal of Clinical Investigation, 116(12): 3229–3239.
Aboulghar, H., Aboulghar, M., Mansour, R., Serour, G. et al. (2001) ‘A prospective controlled study of karyotyping for 430 consecutive babies conceived through intracytoplasmic sperm injection.’, Fertility and Sterility, 76: 249–253.
Abraham, I., Juhasz, G., Kekesi, K.A. and Kovacs, K.J. (1998) ‘Corticosterone peak is responsible for stress-induced elevation of glutamate in the hippocampus.’ Stress, 2: 171–181.
Abrahams, B.S., Tentler, D., Perederiy, J.V., Oldham, M.C. et al. (2007) ‘Genome-wide analyses of human perisylvian cerebral cortical patterning.’, Proceedings of the National Academy of Science USA, 104(45): 17849–17854.
Abramsky, L. and Chapple, J. (1997) ‘47,XXY (Klinefelter syndrome) and 47,XYY: estimated rates of and indication for postnatal diagnosis with implications for prenatal counselling.’, Prenatal Diagnosis, 17: 363–368.
Abramson, C.J., Platt, S.R., Jakobs, C., Verhoeven, N.M. et al. (2003) ‘L-2-hydroxyglutaric aciduria in Staffordshire Bull Terriers.’, Journal of Veterinary Internal Medicine, 17(4): 551–556.
Acácio, G.L., Barini, R., Bertuzzo, C.S., Couto, E.C. et al. (2005) ‘Methylenetetrahydrofolate reductase gene polymorphisms and their association with trisomy 21.’, Prenatal Diagnosis, 25(13): 1196–1199.
Accardo, P.J. and Roseman, B. (2000) ‘By any other name.’, The Journal of Pediatrics, 136(5): 576–577.
Accardo, P. J. and Whitman, B. (1989) ‘Toe walking: a marker for language disorders in the developmentally disabled.’, Clinical Pediatrics, 28(8): 347–350.
Adams, J.B. and Holloway, C. (2004) ‘Pilot study of a moderate dose multivitamin/mineral supplement for children with autistic spectrum disorder.’, Journal of Alternative and Complementary Medicine, 10(6): 1033–1039.
Adams, M., Lucock, M., Stuart, J., Fardell, S. et al. (2007) ‘Preliminary evidence for involvement of the folate gene polymorphism 19 bp deletion-DHFR in occurrence of autism.’, Neuroscience Letters, 422: 24–29.
Afzal, N., Murch, S., Thirrupathy, K., Berger, L. et al. (2003) ‘Constipation with acquired megarectum in children with autism.’ Pediatrics, 112: 939–942.
Afzelius, B.A. (2004) ‘Cilia-related diseases.’, Journal of Pathology, 204: 470–477.
Agre, P. (2006) ‘Aquaporin water channels: from atomic structure to clinical medicine.’ Nanomedicine: Nanotechnology, Biology, and Medicine, 2: 266–267.
Aguilar-Fuentes, J., Fregoso, M., Herrera, M., Reynaud, E. et al. (2008) ‘P8/TTDA overexpression enhances UV-irradiation resistance and suppresses TFIIH mutations in a Drosophila trichothiodystrophy model.’, PLoS Genetics, 4(11): e1000253.
Aguirre, D., Nieto, K., Lazos, M., Pena, Y.R. et al. (2006) ‘Extragonadal germ cell tumors are often associated with Klinefelter syndrome.’, Human Pathology, 37: 477–480.
Agostoni, C., Massetto, N., Biasucci, G., Rottoli, A. et al. (2000) ‘Effects of long-chain polyunsaturated fatty acid supplementation on fatty acid status and visual function in treated children with hyperphenylalaninemia.’, Journal of Pediatrics, 137: 504–509.
Agostoni, C., Verduci, E., Massetto, N., Fiori, L. et al. (2003) ‘Long term effects of long chain polyunsaturated fats in hyperphenylalaninemic children.’, Archives of Disease in Childhood, 88: 582–583.
Agrelo, R. and Wutz, A. (2010) ‘X inactivation and disease.’, Seminars in Cell and Developmental Biology, 21: 194–200.
Airaksinen, E.M. (1974) ‘Tryptophan treatment of infants with Down’s syndrome.’, Annals of Clinical Research, 6(1): 33–39.
Aitken, K.J. (1991) ‘Examining the evidence for a common structural basis to autism.’ Developmental Medicine and Child Neurology, 33: 930–934.
Aitken, K.J. (1998) ‘Behavioural phenotypes.’, Association for Child Psychology and Psychiatry Occasional Papers Series, 15: 5–20.
Aitken, K.J. (2008) ‘Intersubjectivity, affective neuroscience, and the neurobiology of autistic spectrum disorders: a systematic review.’ The Keio Medical Journal, 57(1): 15–36.
Aitken, K.J. (2009) Dietary Interventions in the ASDs – Why They Work When They Do, Why They Don’t When They Don’t. London: Jessica Kingsley Publishers.
Akaboshi, S., Ruiters, J., Wanders, R.J.A., Andresen, B.S. et al. (2001) ‘Divergent phenotypes in siblings with confirmed 2-methylbutyryl-CoA dehydrogenase (2-MBAD) deficiency.’, Journal of Inherited Metabolic Disease, 24(Supp.1): 58.
Akbarnia, B.A., Gabriel, K.R., Beckman, E. and Chalk, D. (1992) ‘Prevalence of scoliosis in neurofibromatosis.’, Spine, 17(8 Suppl): S244–248.
Akefeldt, A. and Gillberg, C. (1991) ‘Hypomelanosis of Ito in three cases with autism and autistic-like conditions.’ Developmental Medicine and Child Neurology, 33: 737–743.
Akefeldt, A., Gillberg, C. and Larsson, C. (1991) ‘Prader-Willi syndrome in a Swedish rural county: epidemiological aspects.’, Developmental Medicine and Child Neurology, 33(8): 715–721.
Akenside, M. (1768) ‘Observations on cancers.’, Medical Transactions of the Royal College of Physicians of London, 1: 64–92.
Akhondzadeh, S., Tajdar, H., Mohammadi, M.R., Mohammadi, M. et al. (2008) ‘A double-blind placebo controlled trial of piracetam added to risperidone in patients with autistic disorder.’, Child Psychiatry and Human Development, 39(3): 237–245.
Al-Ahmari, A., Shah, N., Sung, L., Zipursky, A. and Hitzler, J. (2006) ‘Long-term results of an ultra low-dose cytarabine-based regimen for the treatment of acute megakaryoblastic leukaemia in children with Down syndrome.’ British Journal of Haematology, 133(6): 646–648.
Alarcón, M., Abrahams, B.S., Stone, J.L., Duvall, J.A. et al. (2008) ‘Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene.’, American Journal of Human Genetics, 82(1): 150–159.
Alarcón, M., Cantor, R.M., Liu, J., Gilliam, T.C., Geschwind, D.H., and the AGRE Consortium (2005a) ‘Evidence for a language quantitative trait locus on chromosome 7q in multiplex autism families.’ American Journal of Human Genetics, 70: 60–71.
Alarcón, M., Yonan, A.L., Gilliam, T.C., Cantor, R.M. and Geschwind, D.H. (2005b) ‘Quantitative genome scan and ordered-subsets analysis of autism endophenotypes support language QTLs.’ Molecular Psychiatry, 10: 747–757.
Alberti, A., Pirrone, P., Elia, M., Waring, R.H. and Romano, C. (1999) ‘Sulphation deficit in “low-functioning” autistic children: a pilot study.’ Biological Psychiatry, 46(3): 420–424.
Alcántara, M.A., Villarreal, M.T., Del Castillo, V., Gutiérrez, G. et al. (1999) ‘High frequency of de novo deletions in Mexican Duchenne and Becker muscular dystrophy patients: implications for genetic counselling.’, Clinical Genetics, 55(5): 376–380.
Aldred, S., Moore, K.M., Fitzgerald, M. and Waring, R.H. (2003) ‘Plasma amino acid levels in children with autism and their families.’, Journal of Autism and Developmental Disorders, 33(1): 93–97.
Alexiev, B.A., Lin, X., Sun, C.C. and Brenner, D.S. (2006) ‘Meckel-Gruber syndrome: pathologic manifestations, minimal diagnostic criteria, and differential diagnosis.’, Archives of Pathology and Laboratory Medicine, 130(8): 1236–1238.
Alkan, A., Sigirci, A., Kutlu, R., Ozcan, H. et al. (2005) ‘Neurofibromatosis type 1: diffusion weighted imaging findings of brain.’, European Journal of Radiology, 56: 229–234.
Alkuraya, F.S., Picker, J., Irons, M.B. and Kimonis, V.E. (2005) ‘Smith-Lemli-Opitz syndrome in trisomy 13: how does the mix work?’ Birth Defects Research A: Clinical and Molecular Terat...
